IBDEI340 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49661,1,3,0)
 ;;=3^Dementia w/o Bhv Dstrb,Unsp
 ;;^UTILITY(U,$J,358.3,49661,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,49661,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,49662,0)
 ;;=F01.51^^191^2477^30
 ;;^UTILITY(U,$J,358.3,49662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49662,1,3,0)
 ;;=3^Vascular Dementia w/ Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49662,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,49662,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,49663,0)
 ;;=F01.50^^191^2477^31
 ;;^UTILITY(U,$J,358.3,49663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49663,1,3,0)
 ;;=3^Vascular Dementia w/o Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49663,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,49663,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,49664,0)
 ;;=A81.9^^191^2477^6
 ;;^UTILITY(U,$J,358.3,49664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49664,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,49664,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,49664,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,49665,0)
 ;;=A81.09^^191^2477^8
 ;;^UTILITY(U,$J,358.3,49665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49665,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,49665,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,49665,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,49666,0)
 ;;=A81.00^^191^2477^9
 ;;^UTILITY(U,$J,358.3,49666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49666,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,49666,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,49666,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,49667,0)
 ;;=A81.01^^191^2477^10
 ;;^UTILITY(U,$J,358.3,49667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49667,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,49667,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,49667,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,49668,0)
 ;;=A81.89^^191^2477^7
 ;;^UTILITY(U,$J,358.3,49668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49668,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,49668,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,49668,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,49669,0)
 ;;=A81.2^^191^2477^27
 ;;^UTILITY(U,$J,358.3,49669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49669,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,49669,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,49669,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,49670,0)
 ;;=B20.^^191^2477^17
 ;;^UTILITY(U,$J,358.3,49670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49670,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49670,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,49670,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,49671,0)
 ;;=B20.^^191^2477^18
 ;;^UTILITY(U,$J,358.3,49671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49671,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49671,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,49671,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,49672,0)
 ;;=F10.27^^191^2477^1
 ;;^UTILITY(U,$J,358.3,49672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49672,1,3,0)
 ;;=3^Alc Dep w/ Alc-Induced Persist Dementia
 ;;^UTILITY(U,$J,358.3,49672,1,4,0)
 ;;=4^F10.27
 ;;^UTILITY(U,$J,358.3,49672,2)
 ;;=^5003095
 ;;^UTILITY(U,$J,358.3,49673,0)
 ;;=F19.97^^191^2477^29
 ;;^UTILITY(U,$J,358.3,49673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49673,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
